Yahoo Web Search

Search results

1. • • Prometheus (RXDX) is set to be acquired by Merck for $11 billion, adding Prometheus' lead product candidate, PRA023, to Merck's portfolio.
     finance.yahoo.com/news/prometheus-rxdx-stock-surges-70-125612569.html

     Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck

2. People also ask

   Who owns Prometheus Software?

   • Founded in 1998, Prometheus makes plant maintenance operations and optimization software for sectors including oil and gas, paper, mining and metals and utilities, according to its website. Genstar bought a majority stake in the company for more than $1 billion from Francisco Partners in 2019 and had explored a sale of the company in 2022.

   Advent Is Said to Near Deal for Stake in Prometheus Group - Bloomberg

   www.bloomberg.com/news/articles/2024-05-23/advent-is-said-to-near-deal-for-prometheus-software-firm-stake

   See all results for this question

   Who is Prometheus Biosciences?

   • About Prometheus Biosciences Prometheus Biosciences, Inc. is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases.

   Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc…

   www.businesswire.com/news/home/20230416005034/en/Merck-Strengthens-Immunology-Pipeline-with-Acquisition-of-Prometheus-Biosciences-Inc.

   See all results for this question

   Will Merck buy Prometheus Biosciences?

   • On April 15, 2023, Merck and Prometheus Biosciences entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion. The transaction is expected to close in the third quarter of 2023.

   Prometheus Biosciences Reports First Quarter 2023 Financial Results and

   finance.yahoo.com/news/prometheus-biosciences-reports-first-quarter-200000141.html

   See all results for this question

   Will Advent International buy Prometheus group?

   • Buyout firm Advent International is nearing a deal to acquire a stake in Prometheus Group in a transaction that could value the industrial software company at more than $4 billion, including debt, according to people with knowledge of the matter.

   Advent Is Said to Near Deal for Stake in Prometheus Group - Bloomberg

   www.bloomberg.com/news/articles/2024-05-23/advent-is-said-to-near-deal-for-prometheus-software-firm-stake

   See all results for this question

3. www.bloomberg.com › news › articlesAdvent Is Said to Near Deal for Stake in Prometheus Group ...

   www.bloomberg.com › news › articles

   • Cached

   May 23, 2024 · Buyout firm Advent International is nearing a deal to acquire a stake in Prometheus Group in a transaction that could value the industrial software company at more than $4 billion, including...

4. finance.yahoo.com › news › prometheus-rxdx-stockPrometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck

   finance.yahoo.com › news › prometheus-rxdx-stock

   • Cached

   Apr 17, 2023 · Prometheus (RXDX) is set to be acquired by Merck for $11 billion, adding Prometheus' lead product candidate, PRA023, to Merck's portfolio. Prometheus' stock is up 70%.

5. Videos

   • 

     1:30

     youtube.com

     Prometheus Group Utopia Master Data as a Service Methodology

     14 Jun 2021

     798 views

   • 

     1:01

     youtube.com

     We Are Prometheus Group

     30 Oct 2019

     4.4K views

   • 

     1:10

     tw.tv.yahoo.com

     Prometheus Biosciences stock soars amid $10.8 billion acquisition deal by Merck

     17 Apr 2023

     114.6K views

   View all

6. www.businesswire.com › news › homeMerck Completes Acquisition of Prometheus Biosciences, Inc.

   www.businesswire.com › news › home

   • Cached

   Jun 16, 2023 · Prometheus is now a wholly-owned subsidiary of Merck and the common stock of Prometheus will no longer be listed or traded on the Nasdaq Global Market.

7. www.businesswire.com › news › homeMerck Strengthens Immunology Pipeline with Acquisition of ...

   www.businesswire.com › news › home

   • Cached

   Apr 16, 2023 · Prometheus is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion...

8. www.prnewswire.com › news-releases › adventAdvent International and Leonard Green & Partners to Partner ...

   www.prnewswire.com › news-releases › advent

   • Cached

   Jun 5, 2024 · RALEIGH, N.C., June 5, 2024 /PRNewswire/ -- Prometheus Group ("Prometheus"), a Genstar Capital ("Genstar") portfolio company, announced today that Advent International ("Advent"), joined by...

9. www.marketwatch.com › story › prometheus-sharesPrometheus shares rally 177% as it prepares to move drug into ...

   www.marketwatch.com › story › prometheus-shares

   Dec 7, 2022 · Shares of Prometheus Biosciences Inc. rxdx soared 177.0% in premarket trading on Wednesday after the company said it will advance an experimental therapy into Phase 3 clinical trials for...

10. finance.yahoo.com › news › prometheus-biosciencesPrometheus Biosciences Reports First Quarter 2023 Financial ...

    finance.yahoo.com › news › prometheus-biosciences

    • Cached

    May 9, 2023 · SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,...